The Latest News

International Collaboration Drives Discovery of Link Between Breast/Ovarian Cancer Gene and Stomach Cancer

Submitted by admin on Sat, 01/24/2015 - 08:23

BETHESDA, Md., Jan. 16, 2015 /PRNewswire-USNewswire/ -- A team of scientists from the United States and China has discovered new genetic insights that could change the way oncologists treat gastric cancer, the fourth most common cancer and the second leading cause of cancer death in the world. The investigators, who tested hundreds of gastric cancer tissue samples using advanced whole-genome sequencing technology, published their discovery online on January 12 in the Proceedings of National Academy of Sciences.

USCACA president was interviewed by CCTV-america on cancer issues

Submitted by admin on Wed, 05/07/2014 - 07:25

USCACA president was interviewed by CCTV-america on cancer issues

Check the link here:
http://youtu.be/z5CybZlufQs

CMT and CSCO announce the 2013 Chinese Clinical Oncology Advances Awards

Submitted by Yunguangtong on Sun, 01/26/2014 - 05:34

The 2013 Chinese Clinical Oncology Advancement Award was recently announced. A total of 14 research programs received the award organized by China Medical Tribune (CMT) and the Chinese Society of Clinical Oncology (CSCO). These projects covered a broad spectrum of clinical oncology specialty fields and were published in prestigious journals including Lancet Oncology and Journal of Clinical Oncology. USCACA clinical oncology research experts participated the award review and selection as special panel reviewers.

USCACA partner --CJC Wins the Title of 2013’ the Highest International Impact Academic Journal of China

Submitted by Yunguangtong on Fri, 01/24/2014 - 03:27

"As the partner of the Chinese Journal of Cancer (CJC) for the past 3 years, USCACA is proud to announce that our society journal CJC wins the Title of 2013’s Highest International Impact Academic Journal of China. Below is a news release from Sun Yat-sen University where CJC is headquartered. Members of USCACA have organized a number of special issues on important topics including Cancer Drug Discovery, Systems Biology of Cancer, Cancer Autophagy, Mouse Model of Cancer, Signaling pathways of Cancer."

Four outstanding young Chinese scientists received the 2013 Scholar Award from USCACA and NFCR

Submitted by Yunguangtong on Wed, 01/15/2014 - 05:38

To facilitate and strengthen collaborations among cancer researchers and physicians in the United States and China, the US Chinese Anti-Cancer Association (USCACA) and the National Foundation for Cancer Research (NFCR) have established the Scholar Excellence Award for the USCACA-NFCR Scholar Exchange and Fellowship Program in Basic, Translational, and Clinical Studies.

USCACA partner -- The Chinese Journal of Cancer is supported by the International Impact-promoting Program for Chinese Sci-Tech Journals

Submitted by Yunguangtong on Wed, 01/15/2014 - 04:58

Recently, the International Impact-promoting Program for Chinese Sci-Tech Journals has released the journal selection results. The Chinese Journal of Cancer (CJC), an English journal sponsored by Sun Yat-sen University Cancer Center, gained type B grant support from this program, with an annual national funding of 1,000,000 RMB for 3 consecutive years.

USCACA committee members with Dr. Zhu Chen at 2013 SZENT-GYÖRGYI PRIZE CEREMONY OF NFCR

Submitted by admin on Mon, 05/20/2013 - 09:16

USCACA sponsored a table at the 2013 Szent-Gyorgyi Prize Ceremony of the National Foundation for Cancer Research (NFCR). This year, the prestigious award went to Alex Matter, M.D., CEO of the Experimental Therapeutic Centre of Agency for Science, Technology and Research (A*STAR) in Singapore, Member of the Swiss Academy of Medical Sciences. The award recognizes his tremendous contribution in the development of Gleevec. Dr.

US China Anti-Cancer Association on Facebook

Submitted by 15yank on Sat, 04/27/2013 - 07:26

Check out USCACA on Facebook:
https://www.facebook.com/groups/575928855773109/

Or search:
US Chinese Anti- Cancer Association

USCACA President Wei Zhang and NFCR COO Sujuan Ba visited Xinxiang Medical University

Submitted by luofr on Fri, 10/05/2012 - 08:09

Dr. Wei Zhang, the President of the US Chinese Anti-cancer Association (USCACA), Dr.S ujuan Ba, the Chief Operating Officer of National Foundation for Cancer Research (NFCR), Dr. Kexin Chen, Director of the Department of Epidemiology and Director of Tissue Bank, Tianjin Medical University Cancer Institute and Hospital, visited Xinxiang Medical University on September 10, 2012.

USCACA hosted a symposium in the 7th Chinese Conference on Oncology (CCO)

Submitted by luofr on Thu, 10/04/2012 - 08:35

Beijing, September 8. Invited by Chinese Anti-Cancer Association, USCACA hosted a special symposium on Collaboration between US and China in Cancer Research. Drs. Wei Zhou and Wancai Yang chaired the symposium. Six experts from US and China (Yunguang Tong, Shi-Yuan Cheng, Zhimin Lv, Wancai Yang, Biao He and Jianmin Fang) introduced their own research and shared experience in a series of topics, including scientific training and career development in US, the difference of research environment, and traps in international collaboration. Drs.

Session Chairs
Session Chairs
Session Chairs

Pages